Publication | Open Access
A pilot study to determine the timing and effect of bevacizumab on vascular normalization of metastatic brain tumors in breast cancer
29
Citations
28
References
2016
Year
ClinicalTrials.gov, identifier NCT01281696 , registered prospectively on December 24, 2010.
| Year | Citations | |
|---|---|---|
Page 1
Page 1